
|Articles|October 9, 2015
MS Drug Cancer Link Rebuffed Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/ms-drug-cancer-link-rebuffed-highlights-specialty-" target="_blank">View the story "MS Drug Cancer Link Rebuffed Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
2
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
3
FDA Approves Sibeprenlimab for Patients with IgAN
4
Navigating Research Disruptions: The Impact of NIH Grant Terminations and the Pharmacist’s Expanding Role
5

















































































































































































































